Histological Evidence of Increased Osteoclast Cell Number and Asymmetric Bone Resorption Activity in the Tibiae of Interleukin-6-Deficient Mice

Association of IL-6 G-174C polymorphism with bone mineral density

(2013) Yuanyuan Ni et al.   JOURNAL OF BONE AND MINERAL METABOLISM

IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro

(2013) Shoichi Kaneshiro et al.   JOURNAL OF BONE AND MINERAL METABOLISM

The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation

(2013) Rachelle W Johnson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fetal bone growth directly and locally impaired by IL-6

(2013) Bryony Jones   Nature Reviews Rheumatology

Combination of Tumor Necrosis Factor α and Interleukin-6 Induces Mouse Osteoclast-like Cells With Bone Resorption Activity Both In Vitro and In Vivo

(2013) Kazuhiro Yokota et al.   Arthritis & Rheumatology

Age-dependent vulnerability to experimental acute pancreatitis is associated with increased systemic inflammation and thrombosis

(2012) Daiki Okamura et al.   AGING CELL

GP130 cytokines and bone remodelling in health and disease

(2011) Natalie A. Sims et al.   BMB Reports

High fat diet-induced animal model of age-associated obesity and osteoporosis

(2010) Ganesh V. Halade et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The dual role of IL-6-type cytokines on bone remodeling and bone tumors

(2008) Frédéric Blanchard et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Interleukin-6 Inhibits Receptor Activator of Nuclear Factor κB Ligand-Induced Osteoclastogenesis by Diverting Cells into the Macrophage Lineage: Key Role of Serine727Phosphorylation of Signal Transducer and Activator of Transcription 3

(2008) Laurence Duplomb et al.   ENDOCRINOLOGY

Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways

(2008) Fumio Yoshitake et al.   JOURNAL OF BIOLOGICAL CHEMISTRY